New York, NY, United States of America

Randi B Silver

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Cornell University. Active years: 2005-2022.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Randi B Silver: Innovator in Neonatal and Ophthalmic Treatments

Introduction

Randi B Silver is a prominent inventor based in New York, NY (US). She has made significant contributions to the fields of neonatal health and ophthalmology. With a total of 3 patents, her work focuses on innovative treatments that address critical health issues.

Latest Patents

One of her latest patents is titled "HIF-stabilization and prevention of hyperoxia-induced neonatal lung disease." This patent discloses a method that involves administering HIF stabilizing small molecule drugs to premature infants. These infants often rely on mechanical ventilation and supplemental oxygen, making them vulnerable to the harmful effects of hyperoxia on lung development. Research conducted in a mouse model supports the efficacy of HIF stabilizers in protecting lung health during high oxygen exposure. The administration of these stabilizers can occur through various routes, including aerosolized delivery via a ventilator, intravenous, intraperitoneal, or subcutaneous injection.

Another significant patent by Randi B Silver is "Mast cell inhibition in diseases of the retina and vitreous." This application outlines methods for treating or preventing ophthalmic retinal vascular permeability, angiogenic, or fibroproliferative diseases. The treatment involves administering a composition that inhibits mast cell migration, proliferation, or secretion in the vitreous or retina, providing a novel approach to managing these conditions.

Career Highlights

Randi B Silver has worked with esteemed institutions such as Cornell University and the Cornell Research Foundation Inc. Her research and innovations have garnered attention in the medical community, particularly for their potential to improve patient outcomes in vulnerable populations.

Collaborations

Throughout her career, Randi has collaborated with notable colleagues, including Stefan Worgall and Nathan O'Connor. These partnerships have contributed to the advancement of her research and the development of her patented technologies.

Conclusion

Randi B Silver is a trailblazer in the fields of neonatal and ophthalmic health, with her innovative patents addressing critical medical challenges. Her work exemplifies the impact of research and innovation on improving health outcomes for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…